Circulomics Awarded $1.5M Phase II SBIR to Develop Multiplex microRNA Assay
May 13, 2015 09:17 ET
|
Circulomics
BALTIMORE, MD--(Marketwired - May 13, 2015) - Circulomics Inc has been awarded a $1.5M Phase II Small Business Innovation Research (SBIR) grant by the National Institutes of Health (NIH) - National...
Circulomics Awarded Phase I SBIR to Develop Nanobind DNA Extraction Technology
April 30, 2014 10:12 ET
|
Circulomics
BALTIMORE, MD--(Marketwired - April 30, 2014) -
Circulomics Inc has been awarded a Phase I Small Business Innovative Research (SBIR) grant by the National...
Champions Oncology and Teva Sign a Discovery and Drug Development Partnership
September 12, 2013 16:07 ET
|
Champions Oncology
HACKENSACK, N.J., Sept. 12, 2013 (GLOBE NEWSWIRE) -- Champions Oncology Inc. (OTC:CSBR) ("Champions"), a company engaged in the development of advanced technology solutions and services to personalize...
MolecularMD Corp. Obtains License to Commercialize Predictive Diagnostic Based on Actionable Biomarker, DDR2, for Uses in Lung Cancer and Targeted Kinase Therapy
July 29, 2013 08:05 ET
|
MolecularMD
PORTLAND, OR--(Marketwired - Jul 29, 2013) - MolecularMD Corp. announced today that it has entered into a license agreement granting the company exclusive patent rights to cancer diagnosis...
Circulomics Awarded Nearly $1M to Develop Multiplex MicroRNA Assay
December 10, 2012 09:21 ET
|
Circulomics Inc
BALTIMORE, MD --(Marketwire - December 10, 2012) -
Circulomics Inc has been awarded two Small Business Innovative Research (SBIR) Phase I awards, totaling $800k...